PB2578: ANTIBODY RESPONSE TO SARS-COV-2 OMICRON VARIANT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER THE BREAKTHROUGH INFECTION WAVE IN CHONGQING, CHINA: A MULTI-CENTER, PROSPECTIVE STUDY
LI Jun,
Ding Yao,
Zhang Yong,
Liu Zhanshu,
Zailin Yang,
Yang Zailiang,
Liu Tingting,
Xiaomei Zhang,
Yi Liu,
Tang Yifeng,
Huihui Fu,
Sanxiu He,
Yao Liu
Affiliations
LI Jun
1 Chongqing University Cancer Hospital, Department of Hematology-Oncology, Chongqing, China
Ding Yao
1 Chongqing University Cancer Hospital, Department of Hematology-Oncology, Chongqing, China
Zhang Yong
3 the Third Affiliated Hospital of Chongqing Medical University, Department of Hematology, Chongqing, China
Liu Zhanshu
4 Yongchuan Hospital of Chongqing Medical University, Department of Hematology, Chongqing, China
Zailin Yang
2 Chongqing University Cancer Hospital, Department of Hematology-Oncology, Chongqing, China
Yang Zailiang
5 Chongqing University Fuling Hospital, Department of Hematology, Chongqing, China
Liu Tingting
2 Chongqing University Cancer Hospital, Department of Hematology-Oncology, Chongqing, China
Xiaomei Zhang
2 Chongqing University Cancer Hospital, Department of Hematology-Oncology, Chongqing, China
Yi Liu
2 Chongqing University Cancer Hospital, Department of Hematology-Oncology, Chongqing, China
Tang Yifeng
2 Chongqing University Cancer Hospital, Department of Hematology-Oncology, Chongqing, China
Huihui Fu
2 Chongqing University Cancer Hospital, Department of Hematology-Oncology, Chongqing, China
Sanxiu He
2 Chongqing University Cancer Hospital, Department of Hematology-Oncology, Chongqing, China
Yao Liu
2 Chongqing University Cancer Hospital, Department of Hematology-Oncology, Chongqing, China
